Adavosertib
WEE1 Kinase Inhibitor
- CAS
- 955365-80-7
- Formula
- C27H32N8O2
- Mol. weight
- 500.61 g/mol
- Purity
- ≥99%
Added. View your enquiry →
Price on request. CoA, HPLC, NMR and SDS available on request. For Research Use Only. Not for human or veterinary use.
Adavosertib (MK-1775) is an ATP-competitive WEE1 kinase inhibitor that abrogates the G2/M DNA damage checkpoint by preventing inhibitory phosphorylation of CDK1 (Tyr15). This forces checkpoint-deficient cancer cells (commonly p53-mutant) into mitotic catastrophe following DNA damage. Extensively studied in combination with DNA-damaging chemotherapy and PARP inhibitors; active in CCNE1-amplified ovarian cancer.
Target class: DNA damage response (DDR) inhibitors
Research areas: Colorectal Cancer, Lung Cancer, Ovarian Cancer
Related compounds
| SMILES | CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O |
|---|---|
| InChIKey | BKWJAKQVGHWELA-UHFFFAOYSA-N |
